Clinical Trials Logo

Endophthalmitis Postoperative clinical trials

View clinical trials related to Endophthalmitis Postoperative.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03634852 Completed - Clinical trials for Endophthalmitis Postoperative

A Two Chemoprophylaxis Approaches After Phacoemulsification Surgery

Start date: October 1, 2016
Phase: Phase 4
Study type: Interventional

Post cataract surgery bacterial endophthalmitis is a rare but the most devastating complication with a poor visual outcome. The preferred pattern of chemoprophylaxis varied world widely. The use of preoperative povidone iodine is universal. Most European surgeons prefer the use of Intracameral (IC) antibiotics whereas topical fluoroquinolone that prescribed perioperatively is the most common pattern in the United state(US). The current study aimed to evaluate the effectivity and safety of a combination of diluted IC Moxifloxacin and subconjunctival (SC) Triamcinolone acetonide as prophylaxis of bacterial endophthalmitis and postoperative inflammation in five hundred phacoemulsification surgeries and compare its results with the same number of patients treated by topical Moxifloxacin hydrochloride and Dexamethasone eye drops when given four times a day for 1month postoperatively.